Hydroxamate based inhibitors of adenylyl cyclase. Part 2: the effect of cyclic linkers on P-site binding.
The adenylyl cyclases (ACs) are a family of enzymes that are key elements of signal transduction by virtue of their ability to convert ATP to cAMP. The catalytic mechanism of this transformation proceeds through initial binding of ATP to the purine binding site (P-site) followed by metal mediated cyclization with loss of pyrophosphate. Previous work in our group identified novel inhibitors which possess an adenine ring joined to a metal-coordinating hydroxamic acid through flexible linkers. Considering the spatial positioning of the metals with respect to the adenine binding site coupled with potentially favorable entropic factors, conformational restriction of the tether through a stereochemistry based SAR employing a rigid cyclic scaffold was explored.
Levy
Daniel
D
Millennium Pharmaceuticals, Inc., 256 East Grand Avenue, South San Francisco, CA 94080,USA. san.levy@mpi.com
Bao
Ming
M
Tomlinson
James
J
Scarborough
Robert
R
D000067956:Adenylyl Cyclase Inhibitors; D001665:Binding Sites; D002460:Cell Line; D018360:Crystallography, X-Ray; D003517:Cyclopentanes / Q000737:chemistry; D004791:Enzyme Inhibitors / Q000138:chemical synthesis* / Q000494:pharmacology*; D006801:Humans; D006860:Hydrogen Bonding; D006877:Hydroxamic Acids / Q000138:chemical synthesis* / Q000494:pharmacology*; D007202:Indicators and Reagents; D007527:Isoenzymes / Q000037:antagonists & inhibitors; D007668:Kidney / Q000187:drug effects / Q000201:enzymology; D008274:Magnesium / Q000737:chemistry; D011487:Protein Conformation; D011983:Receptors, Purinergic / Q000187:drug effects*; D013237:Stereoisomerism; D013329:Structure-Activity Relationship
D000067956:Adenylyl Cyclase Inhibitors; D003517:Cyclopentanes; D004791:Enzyme Inhibitors; D006877:Hydroxamic Acids; D007202:Indicators and Reagents; D007527:Isoenzymes; D011983:Receptors, Purinergic; D008274:Magnesium